University of Colorado Aurora, Colorado, United States
Background/Case Studies: Platelet (PLT) shortages have become a significant concern in the transfusion community. Collection thresholds have been lowered in many countries to 2.4 x 1011 PLTs/unit to increase collections without relying on more donations. The PLADO study (2010) showed the U.S. standard dose of 3 x 1011 PLTs/unit exceeds what is necessary for prophylactic use. As suppliers increasingly deliver low-yield (LY) units, we sought to demonstrate that the post-transfusion response from these units provided a clinically equivalent PLT count increase compared with standard (STD) units.
Study
Design/Methods: From July through December 2024, LY units were randomly administered per routine ordering. Patients who received a LY unit were retrospectively chart reviewed for demographics, pre- and post-transfusion PLT counts, and bleeding events. The same data were collected for STD units transfused to those patients before or after the LY units, enabling within-patient comparison of PLT count response. Individual product PLT counts and volumes were obtained from suppliers and the change in counts calculated. A one way ANOVA was used to compare post counts in those patients (n=7) who had a STD PLT unit (STD1), followed by a LY unit, followed by another STD unit (STD 2; Figure 1).
Results/Findings: Fourteen LY units were transfused to 12 patients in the 6-month period reviewed. All LY transfusions had at least 1 corresponding STD transfusion for comparison (29 STD units total). The average PLT dose was 2.85 x 1011 PLT (2.66-2.95 x 1011 PLT) and 3.65 x 1011 PLT for the LY and STD units, respectively.
Of the units reviewed, 1 patient was excluded from the analysis (1 LY unit and 4 STD units) due to lack of a post-transfusion count associated with the LY unit and 1 STD unit was excluded due to lack of post-count information. Post-transfusion counts were taken between 15min and 12 hrs and 57 minutes post transfusion, with one LY unit’s post-counts not taken until 22 hrs and 58 minutes. That unit was included in analysis. Of the units reviewed, 77% of LY and 88% of STD units achieved post-transfusion PLT count increases > 5 x 109/L when compared to the pre-transfusion count. No statistical difference was identified in the post-transfusion PLT count increase by unit type (Figure 1) and no bleeding events related to LY PLT administration were identified.
Conclusions: Consistent with prior studies, no significant difference was found in the post-transfusion counts of patients who received LY vs STD units. All LY units met or exceeded the 2.5 x 1011 PLT/unit count recommended as an updated lower platelet threshold.1
These findings support the proposed reduction in the current platelet collection yield recommended by FDA guidance. Based on our literature review and small in-house comparison, LY PLTs will continue to be accepted into our inventory and distributed as a part of standard inventory.